Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized ，Placebo-controlled,Single-dose Escalation Trial of M2ES in Healthy Volunteer

NCT01223924 is registered in ClinicalTrials.gov with Beijing Protgen Biotechnology Development Co., Ltd. as lead sponsor.

NCT NCT01223924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01223924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized ，Placebo-controlled,Single-dose Escalation Trial of M2ES in Healthy Volunteer
Lead sponsor
Beijing Protgen Biotechnology Development Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2009
Completion date
September 30, 2009
Enrollment
33 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer